Report Detail

Pharma & Healthcare Global Hematopoietic Stem Cell Transplantation (HSCT) Market Insights, Forecast to 2025

  • RnM2873061
  • |
  • 04 February, 2019
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Hematopoietic Stem Cell Transplantation (HSCT) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hematopoietic Stem Cell Transplantation (HSCT) market based on company, product type, end user and key regions.

This report studies the global market size of Hematopoietic Stem Cell Transplantation (HSCT) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hematopoietic Stem Cell Transplantation (HSCT) in these regions.
This research report categorizes the global Hematopoietic Stem Cell Transplantation (HSCT) market by top players/brands, region, type and end user. This report also studies the global Hematopoietic Stem Cell Transplantation (HSCT) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Regen Biopharma Inc
China Cord Blood Corp
CBR Systems Inc
Escape Therapeutics Inc
Cryo-Save AG
Lonza Group Ltd
Pluristem Therapeutics Inc
ViaCord Inc

Market size by Product
Allogeneic
Autologous
Market size by End User
Peripheral Blood Stem Cells Transplant (PBSCT)
Bone Marrow Transplant (BMT)
Cord Blood Transplant (CBT)

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Hematopoietic Stem Cell Transplantation (HSCT) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hematopoietic Stem Cell Transplantation (HSCT) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hematopoietic Stem Cell Transplantation (HSCT) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hematopoietic Stem Cell Transplantation (HSCT) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hematopoietic Stem Cell Transplantation (HSCT) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hematopoietic Stem Cell Transplantation (HSCT) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Hematopoietic Stem Cell Transplantation (HSCT) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size Growth Rate by Product
      • 1.4.2 Allogeneic
      • 1.4.3 Autologous
    • 1.5 Market by End User
      • 1.5.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size Growth Rate by End User
      • 1.5.2 Peripheral Blood Stem Cells Transplant (PBSCT)
      • 1.5.3 Bone Marrow Transplant (BMT)
      • 1.5.4 Cord Blood Transplant (CBT)
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size
      • 2.1.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue 2014-2025
      • 2.1.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Sales 2014-2025
    • 2.2 Hematopoietic Stem Cell Transplantation (HSCT) Growth Rate by Regions
      • 2.2.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Sales by Regions
      • 2.2.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Hematopoietic Stem Cell Transplantation (HSCT) Sales by Manufacturers
      • 3.1.1 Hematopoietic Stem Cell Transplantation (HSCT) Sales by Manufacturers
      • 3.1.2 Hematopoietic Stem Cell Transplantation (HSCT) Sales Market Share by Manufacturers
      • 3.1.3 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Manufacturers
      • 3.2.1 Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hematopoietic Stem Cell Transplantation (HSCT) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Hematopoietic Stem Cell Transplantation (HSCT) Price by Manufacturers
    • 3.4 Hematopoietic Stem Cell Transplantation (HSCT) Manufacturing Base Distribution, Product Types
      • 3.4.1 Hematopoietic Stem Cell Transplantation (HSCT) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Hematopoietic Stem Cell Transplantation (HSCT) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Hematopoietic Stem Cell Transplantation (HSCT) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Sales by Product
    • 4.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Product
    • 4.3 Hematopoietic Stem Cell Transplantation (HSCT) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Breakdown Data by End User

    6 North America

    • 6.1 North America Hematopoietic Stem Cell Transplantation (HSCT) by Countries
      • 6.1.1 North America Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries
      • 6.1.2 North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Hematopoietic Stem Cell Transplantation (HSCT) by Product
    • 6.3 North America Hematopoietic Stem Cell Transplantation (HSCT) by End User

    7 Europe

    • 7.1 Europe Hematopoietic Stem Cell Transplantation (HSCT) by Countries
      • 7.1.1 Europe Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries
      • 7.1.2 Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Hematopoietic Stem Cell Transplantation (HSCT) by Product
    • 7.3 Europe Hematopoietic Stem Cell Transplantation (HSCT) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) by Countries
      • 8.1.1 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries
      • 8.1.2 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) by Product
    • 8.3 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) by End User

    9 Central & South America

    • 9.1 Central & South America Hematopoietic Stem Cell Transplantation (HSCT) by Countries
      • 9.1.1 Central & South America Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries
      • 9.1.2 Central & South America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Hematopoietic Stem Cell Transplantation (HSCT) by Product
    • 9.3 Central & South America Hematopoietic Stem Cell Transplantation (HSCT) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) by Countries
      • 10.1.1 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Sales by Countries
      • 10.1.2 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) by Product
    • 10.3 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) by End User

    11 Company Profiles

    • 11.1 Regen Biopharma Inc
      • 11.1.1 Regen Biopharma Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Products Offered
      • 11.1.5 Regen Biopharma Inc Recent Development
    • 11.2 China Cord Blood Corp
      • 11.2.1 China Cord Blood Corp Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Products Offered
      • 11.2.5 China Cord Blood Corp Recent Development
    • 11.3 CBR Systems Inc
      • 11.3.1 CBR Systems Inc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Products Offered
      • 11.3.5 CBR Systems Inc Recent Development
    • 11.4 Escape Therapeutics Inc
      • 11.4.1 Escape Therapeutics Inc Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Products Offered
      • 11.4.5 Escape Therapeutics Inc Recent Development
    • 11.5 Cryo-Save AG
      • 11.5.1 Cryo-Save AG Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Products Offered
      • 11.5.5 Cryo-Save AG Recent Development
    • 11.6 Lonza Group Ltd
      • 11.6.1 Lonza Group Ltd Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Products Offered
      • 11.6.5 Lonza Group Ltd Recent Development
    • 11.7 Pluristem Therapeutics Inc
      • 11.7.1 Pluristem Therapeutics Inc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Products Offered
      • 11.7.5 Pluristem Therapeutics Inc Recent Development
    • 11.8 ViaCord Inc
      • 11.8.1 ViaCord Inc Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Products Offered
      • 11.8.5 ViaCord Inc Recent Development

    12 Future Forecast

    • 12.1 Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast by Regions
      • 12.1.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue Forecast by Regions 2019-2025
    • 12.2 Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast by Product
      • 12.2.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue Forecast by Product 2019-2025
    • 12.3 Hematopoietic Stem Cell Transplantation (HSCT) Market Forecast by End User
    • 12.4 North America Hematopoietic Stem Cell Transplantation (HSCT) Forecast
    • 12.5 Europe Hematopoietic Stem Cell Transplantation (HSCT) Forecast
    • 12.6 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Forecast
    • 12.7 Central & South America Hematopoietic Stem Cell Transplantation (HSCT) Forecast
    • 12.8 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Hematopoietic Stem Cell Transplantation (HSCT) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Hematopoietic Stem Cell Transplantation (HSCT) . Industry analysis & Market Report on Hematopoietic Stem Cell Transplantation (HSCT) is a syndicated market report, published as Global Hematopoietic Stem Cell Transplantation (HSCT) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Hematopoietic Stem Cell Transplantation (HSCT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,400.00
      $5,850.00
      $7,800.00
      2,720.00
      4,680.00
      6,240.00
      3,175.60
      5,463.90
      7,285.20
      534,922.00
      920,380.50
      1,227,174.00
      283,526.00
      487,831.50
      650,442.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report